Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhinnaoshen (智脑参) appears to be a non-specific term, likely referring to a product or category of products aimed at brain health and cognitive function, rather than a single, identifiable pharmaceutical drug. The Chinese name literally translates to "Wisdom Brain Ginseng" or "Intelligent Brain Ginseng," suggesting it may be a traditional Chinese medicine (TCM) product or a dietary supplement that potentially contains ginseng or other ingredients believed to support cognitive abilities. Extensive searches did not yield information about a specific pharmaceutical drug with this exact name, its developers, manufacturers, or a singular, well-defined mechanism of action. Products with similar names or functions found in searches are typically classified as health supplements or traditional remedies, often containing multiple ingredients to enhance memory, focus, or overall brain vitality.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhinnaoshen.